TBPMF News and Press, Tetra Bio-Pharma Inc From 06/25/21

Tetra Bio-Pharma Announces Change in Management Canada NewsWire OTTAWA, ON , June 25, 2021 /CNW/ - Tetra Bio-Pharma Inc. ( " Tetra " or the " Company " ) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a le...

Significant Discovery Reveals New Antiviral Properties of Tetra Bio-Pharma's Innovative Drug ARDS-003 Canada NewsWire Combining ARDS-003 with antiviral drugs significantly decreased viral replication compared to antiviral treatment alone . OTTAWA, O...

NEW YORK, June 11, 2021 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, is highlighting the latest CEO comments and news from companies recently presenting at its highly acclaimed NEXT SUPER STOCK livestream investor conferences, and investor “...

This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated May 28, 2021 to its short form base shelf prospectus dated April 1, 2020 The Company approaches a significant milestone advancing from a pre-revenue biotech to in reve...

Tetra Bio-Pharma Announces Voting Results of 2021 Annual General and Special Meeting Canada NewsWire OTTAWA, ON , May 28, 2021 /CNW/ - Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in ca...

Canadian cannabis producer HEXO (NYSE: HEXO ,TSX:HEXO) showed this week that it isn’t done making purchases, revealing another acquisition. Also this week, a cannabis retailer broke ground by confirming its shares will be heading to a senior exchange in the US. Keep r...

Tetra Bio-Pharma (TBPMF) announces clinical advancements in REBORN1 trial; ARDS-003 trial and update on capital raise. The REBORN1 trial is designed to evaluate the effect of QIXLEEF, against immediate release oral morphine sulfate on onset of pain relief in people living with cancer.The firs...

Tetra Bio-Pharma Announces Clinical Advancements and Establishment of At-the-Market Equity Program Canada NewsWire First REBORN1© patient enters clinical trial. Positive results of first study in Sars-CoV-2 infected mice. Filing of IND for ARDS-0...

Tetra Bio-Pharma Announces Exercise of Over-Allotment Option in Connection with Bought Deal Financing Canada NewsWire /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES / OTTAWA, ON , May 21, 2021 /CNW/ ...

Tetra Bio-Pharma Inc. Announces Changes to its Board of Directors and the Filing of a Supplement to its Management Information Circular Canada NewsWire OTTAWA, ON , May 18, 2021 /CNW Telbec/ - Tetra Bio-Pharma Inc . (" Tetra " or the " Company ")...